Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Anemia, Iron-Deficiency 2Anemia 1Anaemia in Ovarian Carcinoma 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × ferric derisomaltose × Clear all
NCT05407987 2025-04-25

FORGE II

AHS Cancer Control Alberta

Phase 3 Recruiting
82 enrolled
Classical hematology

Anemia, Anemia, Iron-Deficiency

NCT06248749 2024-02-08

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

University of Saskatchewan

Phase 3 Not yet recruiting
200 enrolled
Gynecologic

Anaemia in Ovarian Carcinoma

NCT05467319 2022-07-20

FORGE

Alberta Health Services, Calgary

Phase 3 Unknown
82 enrolled
Classical hematology

Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡